Bellevue Life Sciences Acquisition Stock (NASDAQ:BLAC)
Previous Close
$10.91
52W Range
$10.42 - $11.60
50D Avg
$10.87
200D Avg
$10.74
Market Cap
$44.05M
Avg Vol (3M)
$9.48K
Beta
-0.01
Div Yield
-
BLAC Company Profile
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Industry
Shell Companies
Sector
Financial Services
Exchange
NASDAQ
ADR
-
Country
US
Employees
-
IPO Date
Mar 21, 2023
Website
-